IL314458A - Protein z variants binding thymic stromal lymphopoietin and their medical use - Google Patents
Protein z variants binding thymic stromal lymphopoietin and their medical useInfo
- Publication number
- IL314458A IL314458A IL314458A IL31445824A IL314458A IL 314458 A IL314458 A IL 314458A IL 314458 A IL314458 A IL 314458A IL 31445824 A IL31445824 A IL 31445824A IL 314458 A IL314458 A IL 314458A
- Authority
- IL
- Israel
- Prior art keywords
- protein
- medical use
- thymic stromal
- stromal lymphopoietin
- variants binding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22155646 | 2022-02-08 | ||
| PCT/EP2023/053030 WO2023152144A1 (en) | 2022-02-08 | 2023-02-08 | Protein z variants binding thymic stromal lymphopoietin and their medical use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL314458A true IL314458A (en) | 2024-09-01 |
Family
ID=80682629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL314458A IL314458A (en) | 2022-02-08 | 2023-02-08 | Protein z variants binding thymic stromal lymphopoietin and their medical use |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP4476247A1 (en) |
| JP (1) | JP2025506381A (en) |
| KR (1) | KR20240139058A (en) |
| CN (1) | CN118632866A (en) |
| AR (1) | AR128475A1 (en) |
| AU (1) | AU2023218534A1 (en) |
| CA (1) | CA3251231A1 (en) |
| IL (1) | IL314458A (en) |
| MX (1) | MX2024009732A (en) |
| WO (1) | WO2023152144A1 (en) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE08786222T1 (en) | 2007-07-31 | 2010-11-25 | Affibody Ab | NEW ALBUMIN BINDING COMPOSITIONS, PROCESSES AND APPLICATIONS |
| ES2373832T3 (en) | 2007-12-19 | 2012-02-09 | Affibody Ab | POLYPEPTIDE DERIVED FROM PROTEIN A AND ABLE TO JOIN PDGF. |
| BR112013000452A2 (en) | 2010-07-09 | 2020-02-11 | Affibody Ab | ALBUMIN BINDING POLYPEPTIDE, FUSION OR CONJUGATE PROTEIN, POLYNUCLEOTIDE, METHOD TO PRODUCE A POLYPEPTIDE, COMPOSITION, METHOD FOR THE PREPARATION OF A COMPOSITION, AND, METHOD FOR INCREASING THE SOLUBILITY OF A SOLUBILITY |
| US10155792B2 (en) | 2012-09-25 | 2018-12-18 | Affibody Ab | Albumin binding polypeptide |
| WO2015189430A1 (en) | 2014-06-13 | 2015-12-17 | Affibody Ab | New polypeptide |
| KR20240110106A (en) * | 2015-01-12 | 2024-07-12 | 애피바디 에이비 | Il-17a-binding polypeptides |
| CA3001264A1 (en) | 2015-10-30 | 2017-05-04 | Affibody Ab | Pd-l1 binding polypeptide |
| WO2021089695A1 (en) * | 2019-11-05 | 2021-05-14 | Affibody Ab | Polypeptides |
-
2023
- 2023-02-08 MX MX2024009732A patent/MX2024009732A/en unknown
- 2023-02-08 WO PCT/EP2023/053030 patent/WO2023152144A1/en not_active Ceased
- 2023-02-08 JP JP2024545909A patent/JP2025506381A/en active Pending
- 2023-02-08 EP EP23703451.7A patent/EP4476247A1/en active Pending
- 2023-02-08 KR KR1020247025767A patent/KR20240139058A/en active Pending
- 2023-02-08 AR ARP230100294A patent/AR128475A1/en unknown
- 2023-02-08 AU AU2023218534A patent/AU2023218534A1/en active Pending
- 2023-02-08 CN CN202380019293.5A patent/CN118632866A/en active Pending
- 2023-02-08 IL IL314458A patent/IL314458A/en unknown
- 2023-02-08 CA CA3251231A patent/CA3251231A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2023218534A1 (en) | 2024-07-11 |
| CN118632866A (en) | 2024-09-10 |
| AR128475A1 (en) | 2024-05-15 |
| CA3251231A1 (en) | 2023-08-17 |
| WO2023152144A1 (en) | 2023-08-17 |
| KR20240139058A (en) | 2024-09-20 |
| EP4476247A1 (en) | 2024-12-18 |
| MX2024009732A (en) | 2024-08-19 |
| JP2025506381A (en) | 2025-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202110236B (en) | Antibody capable of binding to thymic stromal lymphopoietin and use thereof | |
| EP4119162A4 (en) | Pvrig binding protein and its medical uses | |
| EP4106806A4 (en) | Flt3 binding proteins and methods of use | |
| IL250900A0 (en) | Antigen binding proteins capable of binding thymic stromal lymphopoietin | |
| IL182422A0 (en) | Prion protein binding materials and methods of use | |
| IL316176A (en) | Siglec-8 binding proteins and uses thereof | |
| LT4051708T (en) | Dry powder formulations of thymic stromal lymphopoietin (tslp)-binding antibodies and methods of use thereof | |
| IL327193A (en) | Cas12 protein and use thereof | |
| ZA202109744B (en) | Anti-connective tissue growth factor antibody and application thereof | |
| HK40118530A (en) | Protein z variants binding thymic stromal lymphopoietin and their medical use | |
| PL371773A1 (en) | Modified human thymic stromal lymphopoietin | |
| EP4499703A4 (en) | ANTIBODIES AGAINST HUMAN SIGLEC-9 AND THEIR USE FOR IMMUNOTHERAPY | |
| EP3958765C0 (en) | Dorsal vertebral fusion set and medical tool handle | |
| IL308973A (en) | Anti-ctla-4 binding proteins and methods of use thereof | |
| IL314129A (en) | Materials and methods of il-1beta binding proteins | |
| EP4446335A4 (en) | Novel peptide and use thereof | |
| EP4212551A4 (en) | Antibody binding human il-5r? and use thereof | |
| EP4056584A4 (en) | NOVEL HUMAN EPIDERMAL GROWTH FACTOR-TF FUSION PROTEIN AND USE THEREOF | |
| CA3310396A1 (en) | Trgv9 binding proteins and medical use thereof | |
| AU2024379650A1 (en) | Trgv9 binding proteins and medical use thereof | |
| EP4119666A4 (en) | LIGHT-SENSITIVE PROTEIN FOR COLOUR RECOGNITION AND ITS USE | |
| HK40130669A (en) | Il-36r binding protein and medicinal use thereof | |
| CA3283398A1 (en) | Il-36r binding protein and medicinal use thereof | |
| IL290649A (en) | cr2 binding proteins and their use in medical treatment | |
| IL275186A (en) | Human anti-grp94 antibodies and uses |